Enzyme-Linked Immunospot Assay
"Enzyme-Linked Immunospot Assay" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A method of detection of the number of cells in a sample secreting a specific molecule. With this method, a population of cells are plated over top of the immunosorbent substrate that captures the secreted molecules.
Descriptor ID |
D058501
|
MeSH Number(s) |
E01.370.225.500.508 E05.200.500.508 E05.242.551 E05.478.566.350.170.500 E05.478.566.380.360.500 E05.478.583.400.170.500 E05.601.470.350.170.500 E05.601.470.380.360.500
|
Concept/Terms |
Enzyme-Linked Immunospot Assay- Enzyme-Linked Immunospot Assay
- Assay, Enzyme-Linked Immunospot
- Assays, Enzyme-Linked Immunospot
- Enzyme Linked Immunospot Assay
- Enzyme-Linked Immunospot Assays
- Immunospot Assay, Enzyme-Linked
- Immunospot Assays, Enzyme-Linked
- ELISPOT
|
Below are MeSH descriptors whose meaning is more general than "Enzyme-Linked Immunospot Assay".
Below are MeSH descriptors whose meaning is more specific than "Enzyme-Linked Immunospot Assay".
This graph shows the total number of publications written about "Enzyme-Linked Immunospot Assay" by people in this website by year, and whether "Enzyme-Linked Immunospot Assay" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2011 | 0 | 4 | 4 |
2012 | 0 | 2 | 2 |
2013 | 0 | 1 | 1 |
2014 | 0 | 3 | 3 |
2016 | 0 | 2 | 2 |
2017 | 5 | 30 | 35 |
2018 | 4 | 10 | 14 |
2019 | 1 | 5 | 6 |
2020 | 0 | 2 | 2 |
2021 | 0 | 5 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Enzyme-Linked Immunospot Assay" by people in Profiles.
-
Surviving Older Patients Show Preserved Cellular and Humoral Immunological Memory Several Months After SARS-CoV-2 Infection. J Gerontol A Biol Sci Med Sci. 2022 01 07; 77(1):33-40.
-
Evaluation of Immune Response and Disease Status in Systemic Lupus Erythematosus Patients Following SARS-CoV-2 Vaccination. Arthritis Rheumatol. 2022 02; 74(2):284-294.
-
Affinity Tag Coating Enables Reliable Detection of Antigen-Specific B Cells in Immunospot Assays. Cells. 2021 07 21; 10(8).
-
Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects. Front Immunol. 2021; 12:693054.
-
Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients. Front Immunol. 2021; 12:684014.
-
SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay. Clin Microbiol Infect. 2021 Jul; 27(7):1029-1034.
-
Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine. Lancet. 2021 03 27; 397(10280):1178-1181.
-
SARS-CoV-2-specific humoral and cellular immunity in two renal transplants and two hemodialysis patients treated with convalescent plasma. J Med Virol. 2021 05; 93(5):3047-3054.
-
A novel STING agonist for cancer immunotherapy and a SARS-CoV-2 vaccine adjuvant. Chem Commun (Camb). 2021 Jan 14; 57(4):504-507.
-
T cell and antibody responses to SARS-CoV-2: Experience from a French transplantation and hemodialysis center during the COVID-19 pandemic. Am J Transplant. 2021 02; 21(2):854-863.